Cancer Communications
indexed by SCI
BMC


Original article
Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells
Christophe Glorieux and Peng Huang
Cancer Communications 2019 39: 41
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/9/2019   doi:10.1186/s40880-019-0386-4
Original Article
Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
Jun-Fang Liao,Qun Zhang, Xiao-Jing Du, Mei Lan, Shan Liu, Yun-Fei Xia, Xiu-Yu Cai and Wei Luo
Cancer Communications 2019 39: 40
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/29/2019   doi:10.1186/s40880-019-0380-x
Editorial
Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
Yuan Zhang, Ying Sun and Jun Ma
Cancer Communications 2019 39: 39
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/25/2019   doi:10.1186/s40880-019-0385-5
Original article
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial
Tianshu Liu, Yanru Qin, Jin Li, Ruihua Xu, Jianming Xu, Shujun Yang, Shukui Qin, Yuxian Bai, Changping Wu, Yixiang Mao, Haiyan Wu, Yilin Ge and Lin Shen
Cancer Communications 2019 39: 38
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/24/2019   doi:10.1186/s40880-019-0384-6
Letter to the Editor
Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression
Jie Wang, Jianzhong Xi, Hanshuo Zhang, Juan Li, Yuchao Xia, Ruibin Xi and Zhijun Xi
Cancer Communications 2019 39: 37
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/21/2019   doi:10.1186/s40880-019-0382-8
Review
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy
Ming Zhou, Xiaoyuan Chen, Hong Zhang, Lin Xia, Xin Tong, Limin Zou, Ruimin Hao, Jianhong Pan, Xiao Zhao, Dongmei Chen, Yuanyuan Song, Yueli Qi, Ling Tang, Zhifang Liu, Rong Gao, Yuankai Shi and Zhimin Yang
Cancer Communications 2019 39: 36
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/20/2019   doi:10.1186/s40880-019-0383-7
Letter to the Editor
Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer
Romano Demicheli, Marco Fornili, Patrizia Querzoli, Massimo Pedriali, Saverio Alberti, Christine Desmedt and Elia Biganzoli
Cancer Communications 2019 39: 35
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/19/2019   doi:10.1186/s40880-019-0381-9
Review
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells
Jean-Fran?ois Rossi, Patrice C?ballos and Zhao-Yang Lu
Cancer Communications 2019 39: 34
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/14/2019   doi:10.1186/s40880-019-0379-3
Letter to the Editor
Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?
Yaxiong Zhang, Lianpeng Chang, Wenfeng Fang, Yunpeng Yang, Lanjun Zhang, Shaodong Hong, Huaqiang Zhou, Yanfang Guan, Xin Yi and Li Zhang
Cancer Communications 2019 39: 33
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/13/2019   doi:10.1186/s40880-019-0378-4
Original article
A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes
Sharvesh Raj Seeruttun, Lipu Xu, Fangwei Wang, Xiaodong Yi, Cheng Fang, Zhimin Liu, Wei Wang and Zhiwei Zhou
Cancer Communications 2019 39: 32
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/10/2019   doi:10.1186/s40880-019-0370-z

<<    Page 1 of 20  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts Editorial Manager to manage its submissions from Dec.18, 2014

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by BioMed Central

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China